Conclusion In trials that specified a duration of dual antiplatelet therapy of six months or more after stent implantation, drug eluting stents seemed safe and effective in people both with and without diabetes.
iFor Wynkel 2004 [ 37], patients were randomly assigned to receive three treatments each over 24 hours in one of the following orders: CVVHD/CVVHpre/CVVHpost, CVVHpre/CVVHpost/CVVHD, or CVVHpost/CVVHD/CVVHpre. jFor parallel group trials; and for crossover trials that specified duration of RRT based on filter failure and not a fixed duration of time.
Trials that reached their originally specified sample size more frequently had a dedicated trial manager, were cancer or drug trials, or offered treatments to patients exclusively available within the trial.
For the analysis on ischaemic stroke, we excluded the trial that did not specify if the analysis was performed according to the intention to treat method.
The original trial protocol specified that HbA1c would be collected at baseline, 3-month follow-up, and 12-month follow-up.
The trial protocol specified that if there was no difference between single treatments, pooled data would be used for comparison with combination treatment.
We carried out a modified intention-to-treat analysis as the trial protocol specified that children without oocysts at randomisation would be excluded from the analysis, as would children with bacterial causes of diarrhoea.
Many cancer clinical trials now specify the particular status of a genetic lesion in a patient's tumor in the inclusion or exclusion criteria for trial enrollment.
Specifically, we propose a statistically rigorous clinical trial design that pre-specifies multiple tests of responder rates between treatment groups based on a range of pre-specified responder cutoffs, and uses the minimum of the p-values for formal inference.
The QRTEngine works by looping a question block according to a predefined list of trial properties that is specified under the "Loop & Merge" functionality.
